Within the PTB group, CD4+ counts did not differ significantly between diabetic and non-diabetic patients (P = 0.881, Supplementary Table S1), suggesting that diabetes status had minimal influence on the main findings. This evidence concerns the gene CD4 and diabetes mellitus.